Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Alisporivir

Generic Name: Alisporivir

Drug Type: Small Molecule

Chemical Formula: C_₆₃H_₁₁₃N_₁₁O_₁₂

CAS Number: 254435-95-5

Unique Ingredient Identifier: VBP9099AA6

Overview

Alisporivir has been used in trials studying the treatment of Hepatitis C and Chronic Hepatitis C.

Background

Alisporivir has been used in trials studying the treatment of Hepatitis C and Chronic Hepatitis C.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Evaluation of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19)

Phase 2

Completed

Posted: 2020/10/29

Sponsor:Assistance Publique ...

ID:NCT04608214

Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients

Phase 3

Completed

Posted: 2016/04/28

Sponsor:Debiopharm Internati...

ID:NCT02753699

Two-way Interaction Between Alisporivir and EDP239

Phase 1

Completed

Posted: 2014/06/25

Sponsor:Enanta Pharmaceutica...

ID:NCT02173574

Alisporivir With RBV in Chronic Hepatitis C Genotype 2 and 3 Participants for Whom Interferon is Not an Option

Phase 2

Completed

Posted: 2014/03/21

Sponsor:Debiopharm Internati...

ID:NCT02094443

Pharmacokinetics and Safety of Alisporivir in Subjects With End Stage Renal Disease on Hemodialysis Compared to Healthy Subjects

Phase 1

Completed

Posted: 2013/11/03

Sponsor:Debiopharm Internati...

ID:NCT01975337

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy